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Diet induced obesity is independent 
of metabolic endotoxemia and 
TLR4 signalling, but markedly 
increases hypothalamic expression 
of the acute phase protein, 
SerpinA3N
Matthew J. Dalby , Gabriella Aviello, Alexander W. Ross, Alan W. Walker  , Perry Barrett & 
Peter J. Morgan  
Hypothalamic inflammation is thought to contribute to obesity. One potential mechanism is via gut 
microbiota derived bacterial lipopolysaccharide (LPS) entering into the circulation and activation of 
Toll-like receptor-4. This is called metabolic endotoxemia. Another potential mechanism is systemic 
inflammation arising from sustained exposure to high-fat diet (HFD) over more than 12 weeks. In this 
study we show that mice fed HFD over 8 weeks become obese and show elevated plasma LPS binding 
protein, yet body weight gain and adiposity is not attenuated in mice lacking Tlr4 or its co-receptor 
Cd14. In addition, caecal microbiota composition remained unchanged by diet. Exposure of mice to HFD 
over a more prolonged period (20 weeks) to drive systemic inflammation also caused obesity. RNAseq 
used to assess hypothalamic inflammation in these mice showed increased hypothalamic expression of 
Serpina3n and Socs3 in response to HFD, with few other genes altered. In situ hybridisation confirmed 
increased Serpina3n and Socs3 expression in the ARC and DMH at 20-weeks, but also at 8-weeks and 
increased SerpinA3N protein could be detected as early as 1 week on HFD. Overall these data show lack 
of hypothalamic inflammation in response to HFD and that metabolic endotoxemia does not link HFD 
to obesity.
Overconsumption of calories within the diet, in the absence of compensatory energy expenditure results in obe-
sity. In part this is due to the failure of the appetite regulatory systems within the hypothalamus of the brain to 
detect and/or adjust to increased energy intake over the long-term. A reason for this failure may be diet itself. 
High-fat diets (HFD) are commonly used to induce obesity in murine and other rodent models. One theory 
that has emerged implicates a chronic inflammatory response in the hypothalamus, induced in rodents through 
feeding of a HFD, which dysregulates the neuroendocrine control of appetite and energy balance. However sys-
temic inflammation arising from HFD can occur at different phases and via different routes. Recently it has been 
reported that the inflammatory response to a HFD occurs in two distinct phases; an early acute phase within a few 
days and a second phase after 12 to 16 weeks1. It is during this latter phase that inflammation from white adipose 
tissue and muscle also become apparent1. Hypothalamic inflammation resulting from long-term HFD-induced 
obesity was first reported in rats, with 29 immune related genes upregulated after 16 weeks feeding of a high-fat 
(45%) diet2. These genes included the cytokine tumour necrosis factor alpha (Tnf), interleukin 1 beta (Il1b), 
interleukin 2 (Il2), and interleukin 6 (Il6), as well as suppressor of cytokine signalling 3 (Socs3) from which it was 
suggested that local inflammation in the hypothalamus resulted in reduced sensitivity to both insulin and leptin 
signalling from the periphery2. Subsequent studies have reported that increased inflammatory gene expression 
can be detected in the hypothalamus of both mice and rats after only 1 to 3 days of high-fat diet feeding and 
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prior to weight gain3. Furthermore, reactive gliosis and evidence of neuronal injury were apparent within the 
first week of HFD feeding in the hypothalamic arcuate nucleus (ARC) of rats and mice, suggesting that obesity is 
associated with inflammatory induced neuronal injury3. It has been suggested that inflammation is not simply a 
consequence of HFD, rather it may also drive obesity4.
Another potential mechanism through which diet could increase inflammation within the hypothalamus 
involves the gut microbiota. It has been proposed that high-fat diets alter the composition of the gut microbiota, 
which in turn leads to increased intestinal permeability and systemic exposure to bacterial lipopolysaccharide 
(LPS). This induces a state of chronic low-grade inflammation that has been called ‘metabolic endotoxemia’5. LPS 
is a highly immunogenic cell surface molecule present in the outer cell membrane of Gram-negative bacteria and 
it is released continuously into the gut lumen through the death of Gram-negative bacteria6. Under normal condi-
tions, LPS translocates across the intestinal epithelium into the circulation, where it is neutralised and detoxified 
after binding to chylomicrons7,8. It has been proposed that high-fat diets alter the composition of the gut microbi-
ota leading to increased numbers of Gram-negative bacteria and increased permeability of the intestinal epithe-
lium9. When LPS was infused subcutaneously into mice over four weeks, to mimic the increase in LPS observed 
on HFD fed animals, an increase in body weight, body fat, and insulin resistance has been reported5. The levels 
of plasma LPS in response to HFD are related to the fat content of the diet and typically these are 1.4 to 2.7 times 
normal levels and are quite distinct from those associated with infection or septic shock, which are 10–50 times 
higher10. From these results it has been suggested that LPS can initiate obesity and insulin resistance representing 
a mechanism of cause and effect between the gut microbiota and body weight change11.
LPS is known to be a ligand for the Toll-like receptor-4 (TLR4), a transmembrane receptor on cells of the 
immune system12, although CD14 (cluster of differentiation-14) is required as a co-receptor for functional effects 
to be expressed13. Mice harbouring loss of function mutations in either Tlr4 or Cd14 genes have been shown to 
have both stronger bones and decreased body fat14 and this provided the first suggested link between TLR4/CD14 
and adiposity. Consistent with this, CD14 deficient mice either fed a very high-fat diet (78% fat) or after low-dose 
LPS infusion were reported to show attenuated weight gain relative to Wild-Type mice on similar treatments5. 
Overall these results appear to demonstrate a causal link between high-fat diet feeding, the gut microbiota, LPS, 
and obesity and provide a basis for the metabolic endotoxemia hypothesis11.
While some studies have similarly reported that loss of function of either TLR4 or CD14 protects against body 
fat gain, insulin resistance, and inflammation in mice fed high-fat diets15–20 other studies have not supported 
such a role for CD1421,22 or TLR423–26 in the control of body weight, while loss of TLR4 still mitigated some other 
negative metabolic effects of HFD feeding. The use of several different knockout mouse strains, both of TLR4 and 
CD14, and a variety of mouse diets has complicated our understanding of the role of the TLR4 pathway in the 
development of obesity. In addition, the influence of CD14 and TLR4 on body weight was not a primary aim in 
several of these studies.
The reasons for these contradictory results are likely to be related to differences in diet and baseline microbi-
ota composition, nature of the loss of function (natural vs knock out) and genetic background. Therefore, in this 
study the aim was to compare the effects of either Tlr4 or Cd14 gene knock-outs in mice on the same genetic back-
ground for diet-induced obesity in response to a HFD. It also examines the long-term effects of HFD on hypo-
thalamic inflammation. The study finds no evidence that metabolic endotoxemia contributes to HFD-induced 
obesity and that HFD increases the expression of only a limited number of genes in the hypothalamus yet none of 
these are prototypical markers of inflammation.
Results
Effect of diet and genotype on food intake, body weight, and body composition. The body weights 
of Wild-Type, Tlr4−/−, and Cd14−/− mice fed HFD significantly increased relative to their respective LFD fed con-
trols over 8 weeks (Fig. 1A). Neither the rate nor extent of body weight gain was affected by genotype. At 8 weeks 
the final mean group body weights of HFD fed Wild-Type, Tlr4−/−, and Cd14−/− were significantly increased 
relative to their respective LFD fed controls (Fig. 1B). Mean energy intake was significantly higher for the HFD 
fed mice relative to their respective LFD fed controls of the same genotype (Fig. 1E). This was despite a tendency 
for reduced average food intake in HFD fed mice (Supplementary Fig. 1C). This resulted from the higher energy 
density of the HFD, which was 21.9 kJ/g compared to 16.1 kJ/g for the LFD (Supplementary Table 1). There were 
no significant differences in mean food or mean energy intake between mouse genotypes fed the LFD or between 
those fed HFD. Neither the TLR4 knockout nor the Cd14 knockout altered food or energy intake compared to 
Wild-Type mice fed the HFD. Increased adiposity accounted for the increased body weight in response to HFD 
by each genotype (Fig. 1C), with a significant accumulation of body fat in each of the HFD groups relative to their 
respective controls (Fig. 1C,D). By contrast there were no differences in the lean mass of any of the experimental 
groups at any time point (Supplementary Fig. 1D–E). Overall neither the Tlr4 nor the Cd14 knockout protected 
mice from the HFD induced increases in body fat.
Effect of high-fat diet and genotype on lipopolysaccharide binding protein concentrations. Serum 
lipopolysaccharide binding protein (LBP) concentrations were measured as a marker of systemic lipopolysaccha-
ride exposure (Fig. 1F). In response to HFD feeding, serum concentrations of LPB in Wild-Type and Cd14−/− 
mice were each significantly increased relative to the LFD controls of their corresponding genotype. In contrast 
there was no significant difference in serum LPB concentrations between the LFD and HFD fed TLR4−/− mice. 
Serum LPB concentrations in HFD fed Wild-Type, Tlr4−/−, and Cd14−/− mice were all significantly higher than in 
Low-Fat diet fed Wild-Type control mice. High-Fat diet feeding increased serum LPB concentrations, suggesting 
increased LPS exposure.
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High fat diet and genotype and the gut microbial composition. Illumina MiSeq sequencing of the V1-V2 
variable region of the 16S ribosomal RNA gene was used to analyse the composition of the caecal microbiota of 
Wild-Type, Tlr4−/−, and Cd14−/− mice after 8 weeks of diet feeding. Comparing the proportional abundance of 
bacterial phyla and families between groups shows clear differences between the Wild-Type and both Tlr4−/− and 
Cd14−/− mice (Fig. 2A). The proportion of Bacteroidetes was higher in Wild-Type mice, compared to Tlr4−/− and 
Cd14−/− mice. The proportional abundance of Firmicutes was significantly lower in LFD than HFD fed Wild-Type 
mice and lower in all Wild-Type mice compared to all Tlr4−/− and Cd14−/− mice (Supplementary Fig. 3A). 
Bacteroidetes, and Proteobacteria were not significantly changed between HFD and LFD fed mice within each 
genotype (Supplementary Fig. 3B,C). The proportion of Actinobacteria was lower in Wild-Type than Tlr4−/− and 
Cd14−/− mice (Supplementary Fig. 3D). The proportion of Deferribacteres was higher in HFD Wild-Type mice 
relative to LFD fed Wild-Type mice but was not detected in either the Tlr4−/− and Cd14−/− mice (Supplementary 
Fig. 3E). There were no differences in the proportions of Verrucomicrobia (Supplementary Fig. 3F). The influ-
ence of diet on microbiota composition at the phylum level was not shared across mouse genotype. The propor-
tional abundance of Gram-negative bacteria was significantly lower in Tlr4−/− and Cd14−/− mice compared to 
Wild-Type mice but was unchanged between HFD and LFD fed mice in each genotype (Supplementary Fig. 3G).
Dendrograms based on the Bray-Curtis dissimilarity index show that the microbiota of Wild-Type mice clus-
ter distinctly from both Tlr4−/− and Cd14−/− mice (Fig. 2B). The microbiota of Wild-Type mice fed LFD and 
HFD clustered closely together and comprised primarily of members of the Firmicutes and Bacteroidetes phyla. 
Strikingly, relatively few differences in the proportion of the bacterial Families could be seen between the LFD 
and HFD groups, irrespective of genotype. In contrast, the microbiota of the Tlr4−/− and Cd14−/− mice were 
composed primarily of Firmicutes in both diets. No clear distinction was observed in the clustering of Tlr4−/− and 
Cd14−/− mice within each diet group. The Tlr4−/− and Cd14−/− mice contained a different microbial composi-
tion that was altered to a greater degree in response to diet than the Wild-Type mice (Fig. 2B). The difference in 
microbiota between LFD fed Tlr4−/− and Cd14−/− mice was primarily due to the greater abundance of an unclas-
sified Firmicutes (OTU1) in LFD fed mice of all genotypes (Fig. 2C). The number of Operational Taxonomic 
Units (OTUs) (Sobs) and estimated total OTU richness (Chao) were lower in Tlr4−/− and Cd14−/− mice com-
pared to Wild-Type mice, while there were no differences between LFD and HFD fed mice within each genotype 
(Fig. 2D–E).
The microbiota diversity of the caecum was measured using the Shannon and Inverse Simpson indices, which 
incorporate species richness and evenness of the community when calculating diversity scores. Shannon and 
Inverse Simpson indices tended to be decreased in the caecal microbiota of Tlr4−/− and Cd14−/− mice compared 
to Wild-Type mice (Fig. 2F–G). The Tlr4−/− and Cd14−/− mice contained a different microbiota composition to 
Figure 1. Effects of diet and genotype on body weight, body fat, energy intake, and LBP. (A) Weekly body 
weight gain; (B) Final total body weight; (C) Weekly body fat gain; (D) Final total body fat; (E) Mean weekly 
kilojoule intake; (F) Serum lipopolysaccharide binding protein (LBP); Data indicate mean ± SEM. ∗p < 0.05, 
∗∗p < 0.01, ∗∗∗p < 0.001; n = 8 mice/group (n = 7 mice/group for HFD Tlr4−/− mice), circles indicate individual 
mice.
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Wild-Type mice. Differences in OTU richness as measured by Sobs and Chao were between Wild-Type mice 
and Tlr4−/− and Cd14−/− mice. However, there were no consistent differences in Shannon and Inverse Simpson 
indexes between diets groups or by genotype.
Gene expression of Tlr2, Tlr4 and Cd14 in the hypothalamus. Expression of Tlr2, Tlr4, and Cd14 
genes in the hypothalamus was assessed by in situ hybridisation in the mouse and rat (Fig. 3). Sections from rat 
brains were used to test probe function due to the difficulty in detecting Tlr4, and Cd14 gene expression in mouse 
Figure 2. Effects of diet and genotype on caecal microbiota composition. (A) Proportional abundance of 
bacterial families in Wild-Type, Tlr4−/−, and Cd14−/− mice fed LFD or HFD with Firmicutes phylum in browns, 
Bacteroidetes in greens, Actinobacteria in blues, and Deferribacteres in black; (B) Proportional abundance of 
bacterial OTUs in Wild-Type, Tlr4−/−, and Cd14−/− mice fed LFD or HFD. Heatmap of proportion of OTUs 
(>3% proportional abundance) in the caecum, with rows clustered by microbiota similarity using the Bray-
Curtis calculator, and columns clustered by OTUs that occur more often together; (C) Proportional abundance 
of OTU1; (D) Species richness (Sobs); (E) Estimated species richness (Chao); (F) Shannon diversity index; (G) 
Inverse Simpson diversity index. Data are mean ± SEM. n = 8 mice/group (n = 7 mice/group for HFD Tlr4−/− 
and LFD Cd14−/− mice), circles indicate individual mice. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
www.nature.com/scientificreports/
5Scientific RepoRts |  (2018) 8:15648  | DOI:10.1038/s41598-018-33928-4
brain sections. While expression of Tlr2 could be detected in the hypothalamo ventricular zone (HVZ) of the 
mouse, expression of both Tlr4 and Cd14 was undetectable. Very weak expression of Tlr4 and Cd14 was detecta-
ble in the hypothalamus of the rat, mainly associated with the HVZ. These findings indicate that any effects of LPS 
through TLR4 or CD14 are unlikely to be through direct action within the hypothalamus.
Effect of high fat diet on hypothalamic gene expression. To capture the effect of a sustained HFD-induced 
inflammatory response, RNAseq was used to analyse differential gene expression within the hypothalamus in 
mice fed either LFD or HFD for 20 weeks (Supplementary Fig. 4). From an initial 46095 reads, 16841 genes were 
expressed sufficiently to permit analysis. Of these only 6 genes had significantly different expression between 
the two diets at a false discovery rate (FDR) ≤ 0.05 (Table 1). All six genes were more highly expressed in mice 
on a HFD relative to a LFD and they have a mixture of functions including serine peptidase inhibitor A3N 
(Serpina3n), transcriptional and intracellular signalling including both the signal transducer and activator of 
transcription 3 (Stat3) and suppressor of cytokine signalling 3 (Socs3) or as pseudogenes with no known func-
tional protein coding capacity. Differential expression of Serpina3n and Socs3 after 20 weeks of high fat relative to 
low fat diet was confirmed by in situ hybridisation (Fig. 4).
Using in situ hybridisation, gene expression for Serpina3n and Socs3 was then assessed in brains from 
Wild-Type, Tlr4−/−, and Cd14−/− mice fed HFD or LFD for only 8 weeks (Fig. 5). This showed that gene expres-
sion of Serpina3n and Socs3 were also both increased in the hypothalamus by HFD relative to LFD after 8 weeks of 
dietary treatment, implying that these are early phase as well as second phase responses. The pattern of expression 
was similar to the changes seen at 20 weeks (Fig. 5A-B). For both Wild-Type and Cd14−/− mice Serpina3n was 
significantly increased in both the ARC and dorsal medial hypothalamus (DMH), although the magnitude of the 
increase was greater in the DMH (Fig. 5F,H). Also, the baseline level of expression for Serpina3n was greater in 
the ARC at 8 weeks relative to 20 weeks (Figs 4 and 5). There were similar increases in Serpina3n expression in the 
ARC (P = 0.051) and the DMH (P = 0.054) between the HFD and LFD in the TLR4−/− mice (Fig. 5G). Socs3 gene 
expression in the hypothalamus of Wild-Type and Cd14−/− mice was also significantly increased after 8 weeks 
HFD dietary treatment relative to LFD controls (Fig. 5C,E), although no difference in expression for this gene was 
observed for Tlr4−/− mice (P = 0.38) (Fig. 5D).
As other studies have previously reported increased expression of other genes have been associated with 
hypothalamic inflammation in mice fed a HFD after 28 days3, Real-Time PCR was used to assess their expres-
sion (Fig. 6). These data show that of the genes tested Socs3 was significantly increased in the hypothalamus of 
Wild-Type mice fed HFD for 8 weeks, but not in TLR4−/− mice relative to their respective LFD controls, consistent 
with in situ hybridisation results (Fig. 6A,B). None of the other inflammatory-related genes tested, Il1, Il-6, Tnf 
Figure 3. Tlr2 and Tlr4 gene expression in the hypothalamus of the mouse and rat. Tlr2 gene expression in 
ependymal cells/tanycytes (hypothalamo-ventricular zone) of mouse (A). Very weak expression of Tlr4 and 
CD14 is detectable in the HVZ of the rat (B,C).
Gene Name Fold change Log fold change P-value FDR Gene description*
Serpina3n 1.7 −0.793236193 5.06E-09 8.52E-05 Serine (or cysteine) peptidase inhibitor
LOC10524359 62.8 −5.972717972 1.87E-07 0.001571933 60S ribosomal protein L23a pseudogene
Stat3 1.2 −0.266379652 1.01E-06 0.005687007 Signal transducer and activator of transcription 3
Gm6210 14.5 −3.86002715 3.88E-06 0.016325199 Heat shock protein 8 pseudogene
Socs3 1.6 −0.655744451 9.62E-06 0.032403367 Suppressor of cytokine signalling 3
GM15459 8.7 −3.112752289 1.44E-05 0.040307169 Heat shock protein 8 pseudogene
Table 1. Genes with significantly increased hypothalamic expression between mice fed high fat diets 
relative to low fat fed controls, identified by edgeR (FDR < 0.05). *As given by NCBI Gene Database. 
Differential expression of 2 of the known genes, Serpina3n and Socs3, was verified using in situ hybridisation 
(Fig. 4). Serpina3n gene is expressed in the arcuate (ARC) and dorsomedial (DMH) nucleus regions of the 
hypothalamus. After 20 weeks of HFD, Serpina3n gene expression was significantly increased in both regions 
compared to mice on LFD, although the magnitude of the change is greatest in the DMH (Fig. 4A,C). Similarly, 
Socs3 gene expression within the hypothalamus also increased by 20 weeks of HFD (Fig. 4B,D).
www.nature.com/scientificreports/
6Scientific RepoRts |  (2018) 8:15648  | DOI:10.1038/s41598-018-33928-4
Figure 4. Effects of 20 weeks of LFD and HFD on hypothalamic Serpina3n and Socs3 expression. (A) In situ 
hybridization expression of Serpina3n in the hypothalamus of LFD and HFD fed Wild-Type mice; (B) In 
situ hybridization expression of Socs3 in the hypothalamus of LFD and HFD fed Wild-Type mice; (C) In situ 
hybridization of Serpina3n expression in the arcuate nucleus (ARC) and dorsal medial hypothalamus (DMH) of 
Wild-Type mice; (D) In situ hybridization of Socs3 expression in the hypothalamus of Wild-type; n = 7–8 mice/
group; Data are mean ± SEM, circles indicate individual mice. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
Figure 5. Effects of 8 weeks of diet and genotype on hypothalamic Serpina3n and Socs3 expression. (A) In situ 
hybridization expression of Serpina3n in the hypothalamus of LFD and HFD fed Wild-Type mice at 3 days 
exposure; (B) In situ hybridization expression of Socs3 in the hypothalamus of LFD and HFD fed Wild-Type 
mice at 7 days exposure; (C) In situ hybridization of Socs3 expression in the arcuate nucleus (ARC) of Wild-
Type mice, (D) Tlr4−/− mice, and (E) Cd14−/− mice; (F) In situ hybridization of Serpina3n expression in the 
arcuate nucleus and dorsal medial hypothalamus of Wild-Type, (G) Tlr4−/−, and (H) Cd14−/− mice; n = 6–9 
mice/group (n = 3–4 mice/group for Tlr4−/−); Data are mean ± SEM, circles indicate individual mice. ∗p < 0.05, 
∗∗p < 0.01, ∗∗∗p < 0.001.
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Nfκb, Cd68, Gfap and Emr1 had altered expression in response to HFD (Fig. 6A,B). Expression of the myeloid 
cell-specific marker Emr1, which has previously been correlated with body fat gain3, showed no such correlation 
(Fig. 6C). Furthermore, the low normalised delta CT values determined using Real Time PCR for Il1b, Il6 and Tnf 
indicate that the expression of these inflammatory genes was very low in the hypothalamus (Supplementary Fig. 2).
Given the finding that Serpina3n gene expression is robustly increased in the hypothalamus in response to 
HFD at both 8 and 20 weeks, we sought to examine the expression of SerpinA3N protein in the hypothalamus. 
Immunoreactive SerpinA3N could be detected in the ARC of Wild-Type mice fed LFD (Fig. 7). Remarkably 
after only 1 week of feeding mice a HFD, increased expression of SerpinA3N immunoreactive protein in the 
DMH could be observed (see arrows Fig. 7), with little change in immunoreactivity in the ARC (Fig. 7). These 
data indicate that increased expression of SerpinA3N is an early and sustained response to HFD. The absence of 
co-localization in the double staining with GFAP showed that SerpinA3N is not expressed by astrocytes in the 
hypothalamus (Supplementary Fig. 5). Instead the shape and location of the immunoreactive staining suggests 
that SerpinA3N is expressed in hypothalamic neurons.
Discussion
In this study whole-body knockout of either Tlr4 or Cd14 in mice did not protect against increased body weight, 
body fat, or energy intake relative to Wild-Type mice, when fed HFD over an 8-week period. Despite this, LBP, a 
biomarker for LPS exposure27–30 increased in response to HFD in both Wild-Type and Cd14−/− mice, suggesting 
that mice fed a HFD were exposed to higher levels of LPS than LFD mice. Together these data argue that LPS, 
which acts via the TLR4/CD14 receptor complex, does not play a role in HFD-induced obesity. This data contra-
dicts two studies in the literature reporting that Cd14−/− mice5,15, and ob/ob Cd14−/− double knockout mice11, 
are protected from high-fat diet induced body fat gain whilst consistent with two studies which have reported 
increased body weight or body fat in HFD fed Cd14−/− mice21,22.
Thus, our results do not support the concept of metabolic endotoxemia and its role in the development of 
obesity, which stemmed from studies showing that Wild-Type mice fed a HFD have chronically elevated levels 
of LPS5. In these studies chronic infusion with low doses of LPS was shown to mimic the effects of HFD-induced 
obesity in mice. Crucially, the effect of HFD on weight gain and other metabolic parameters were attenuated in 
knockout mice lacking CD14, the co-receptor required for the biological activity of LPS5, but our results contrast 
starkly with these.
That Tlr4−/− mice also were not protected against HFD-induced obesity in this study, is consistent with the 
results for Cd14−/− mice, since the latter is a required co-receptor13. However, the effects of Tlr4 knock-outs on 
HFD-induced obesity reported in the literature are contradictory15–17,19,20,22–26. There is no clear explanation for 
the diverse responses that exist, but it is likely that the strain and sex of the mice used, the nature of the knockout 
Figure 6. Effects of diet and Tlr4−/− genotype on hypothalamic inflammatory gene expression. (A) Fold change 
in hypothalamic genes in response to high-fat diet in Wild-Type mice; (B) Fold change in hypothalamic genes 
in response to high-fat diet in Tlr4−/− mice; (C) Correlation of hypothalamic Emr1 mRNA level (linearized 
using difference in CT count between the Gapdh and the Emr1 gene [ΔCT]) with change in fat mass in Wild-
Type mice fed both LFD and HFD (r = 0.01; p = 0.6). mRNA was quantified relative to Gapdh housekeeping 
gene expression (by ΔΔCT method) and presented as fold change relative to LFD-fed controls; Significant 
differences were determined using REST software66; ∗p < 0.05. Values are expressed as the mean ± standard 
error; n = 6 for Wild-Type mice and n = 4 for Tlr4−/− mice.
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(naturally occurring mutation, deletion, or targeted gene knock out), variance in microbiota composition and 
activities, and the type of high-fat diet used are all relevant factors. The current study is the first to directly test the 
effect of both Tlr4 and Cd14 gene knock-outs on HFD-induced obesity in the same study. The consistency of the 
findings strongly supports the conclusion that there is no effect of the TLR4/CD14 receptor complex on weight 
gain, body fat, or food intake in mice.
In addition to acting as a co-receptor for TLR4, CD14 also acts as a co-receptor for Toll-like receptor 2 (TLR2). 
CD14 is required for TLR2 responses to pathogen infection31,32, and is required for bacterial product-induced 
anorexia resulting from TLR2 ligands33. The loss of TLR2 has previously been reported to reduce high-fat 
diet-induced increase in body fat in mice34,35, while other evidence suggests functional hypothalamic neuronal 
TLR2 protects against age-induced obesity36. The lack of any measurable differences in body weight or body fat 
gain seen in Cd14−/− mice, compared to Wild-Type or Tlr4−/− mice, suggests that TLR2 signalling is unlikely to 
have a role in diet-induced obesity.
While the current study finds no evidence for a role of TLR4 /CD14 in HFD-induced obesity, the increase 
in LPB in response to HFD in Wild-Type and Cd14−/− mice is indicative of increased LPS exposure. This is 
consistent with previous observations that HFD increases circulating levels of LPS5. It has been postulated that 
a potential mechanism involved in this process is a change in gut microbial composition9. In the present study 
using 16S rRNA gene sequencing there were relatively few differences in the composition of the caecal microbiota 
between mice on low-fat and high-fat diets, within each genotype. There was no difference in the proportional 
abundance of the Firmicutes and Bacteroidetes phyla due to diet, or in the ratio between them. This contrasts 
with earlier reports of an obesity associated microbiota37, but is consistent with our recent study which shows 
the importance of rigorous dietary control when assessing gut microbial composition38. This is because, if chow 
diets are used as controls for defined high fat diets, then the different levels of fibre between the two diets leads 
to misleading microbiota analysis and interpretation38. However, there are other ways in which the microbiota 
might be playing a role, which would not be detected using solely 16S rRNA gene sequencing. As the LFD was 
high in digestible starch and low in fibre this could reduce bacterial fermentation and short-chain fatty acid 
(SCFA) synthesis, which has been suggested to result in thinning of the gut mucus layer potentially increasing 
bacterial translocation and triggering inflammation39. While caecal SCFA were not determined in this study the 
same diets previously resulted in no differences in caecal SCFA concentrations38. In addition HFD feeding could 
potentially increase the proportion of Gram-negative bacteria in the gut increasing LPS exposure. However, in 
this study the proportion of Gram-negative bacteria was unchanged between in HFD fed mice compared to their 
respective genotype controls.
Figure 7. Effects of diet on hypothalamic SerpinA3N protein expression. SerpinA3N (AF-594 conjugated) 
expression in the ARC and DMH of Wild-Type mice fed with LFD and HFD for one week. Images were 
captured at two different bregma levels and are representative of n = 5 per group. ME: median eminence; 3: third 
ventricle; B: bregma; ARC: arcuate nucleus; DMH: dorsomedial hypothalamus. Scale bar = 100 μm.
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There were however, marked differences between the microbiota composition and diversity of both the 
Tlr4−/− and Cd14−/− mice in comparison to the Wild-Type mice. The loss of TLR4 signalling potentially influ-
ences microbiota composition as the TLR4 is one of the pattern recognition receptors through which bacteria in 
the gut shape the host’s immune tolerance and responsiveness. However, homozygous TLR4 knockout mice do 
not have significantly different caecal microbiota composition relative to heterozygous littermates, suggesting that 
familial transmission is more important than genotype40. Recent research indicates that the intestinal microbiota 
composition of mice varies between different facilities41 and even between mice maintained in different rooms 
within the same animal facility42 and this could be a potential explanation for the observed differences in micro-
biota composition.
Overall Wild-Type mice did not show an obesity associated microbiota despite large increases in body fat 
in high-fat fed Wild-Type mice. This is consistent with our previous findings38 and re-confirms that change in 
microbiota composition is not a prerequisite for obesity development. The major differences in gut microbial 
composition of the Tlr4−/− and Cd14−/− mice did not lead to differences in susceptibility to obesity compared to 
the Wild-Type mice. Thus, these results suggest that the development of HFD-induced obesity in mice can be dis-
associated from changes in the composition of the caecal microbiota and is therefore unlikely to have contributed 
to differences in circulating LPS.
While this study shows that neither Tlr4 and Cd14 have a role in the HFD-induced obesity HFD has the 
potential to influence obesity development through Tlr4 and Cd14 independent pathways. Thus other systemic 
inflammatory responses associated with HFD provide alternative ways of driving hypothalamic inflammation2,3. 
This inflammation has also been linked to hypothalamic resistance to insulin and leptin signalling, potentially 
contributing to energy imbalance and obesity43.
Given that the inflammatory response to HFD occurs in two distinct phases, an acute short term response 
(days) and a longer-term response (>12–16 weeks)1, RNAseq was carried out on hypothalamic tissue from mice 
fed either LFD or HFD for 20-weeks, to capture the long-term effects of systemic inflammation on the hypo-
thalamic response. Suprisingly, few gene expression changes were observed, contrasting to a previous report in 
Wistar rats where 29 immune-related genes were upregulated, including Tnfα, Il1β, and Il6 after exposure to 
HFD for 16 weeks2. Of the selected inflammatory genes reported as upregulated in rats in response to high-fat 
diet induced obesity3, only Socs3 expression was significantly altered in the present study. This response to HFD 
was seen at both 8 and 20-week time points indicating that it is both a short-term as well as long term response 
to HFD. Such increased expression of Socs3 in the hypothalamus is likely to reflect increased resistance to insulin 
and leptin signalling, which is known to occur in HFD-induced obesity44. The increase in Socs3 expression in 
Cd14−/− mice also shows that TLR4 signalling is not required for this response.
A striking finding from these studies is that expression of the gene encoding the acute-phase protein 
SerpinA3N is robustly up-regulated in the ARC and DMH of mice fed HFD at both 8 and 20 weeks relative to 
LFD fed controls. Serpina3n encodes the protein alpha 1-antichymotrypsin, which is mainly produced in the liver 
and involved in the resolution of inflammation and wound healing45. In the brain SerpinA3N has been reported 
to be a marker of reactive astrogliosis46, however in this study its expression was not associated with astrocytes. 
SerpinA3N has also recently been shown to induce neuroprotection both in vitro and in mouse models of neu-
rodegenerative disease47 and increased Serpina3n gene expression was the only gene found to be upregulated in 
the hypothalamus of mice in another recent study of the response to HFD feeding48. Interestingly, immunofluo-
rescence staining showing increased SerpinA3N protein expression can be observed after just one week of high 
fat diet feeding, consistent with early responses to HFD in the hypothalamus seen in other studies49. This shows 
that increased Serpina3n expression in the hypothalamus is both a rapid as well as sustained response to HFD.
Overall these results show that changes in hypothalamic gene expression in response to 8 and 20 weeks of 
high-fat diet feeding were limited to a small number of genes but none of these are prototypical inflammatory or 
immune responses. The increase in Serpina3n mRNA expression suggests a response to undetected inflammation 
or neuronal damage, whereas the increase in Socs3 mRNA expression probably reflects increased insulin and 
leptin resistance in the hypothalamus. Hypothalamic endoplasmic reticulum stress due to increased ceramide, a 
lipotoxic metabolite of fatty acid metabolism, is an alternative pathway of hypothalamic damage in high-fat diet 
fed mice50,51. As neither the Serpina3n nor Socs3 responses were abrogated in Cd14 knockout mice, then neither 
of these responses involve TLR4 and therefore are not induced by LPS.
In conclusion these results show susceptibility to a high fat diet is independent of TLR4 signalling and do not 
support the concept of metabolic endotoxemia as a determinant of obesity. We also conclude that caecal microbi-
ota composition or diversity is not consistently altered within genotypes as a result of consuming a high fat diet. 
This data therefore does not support the notion that changes in the proportional composition of the gut micro-
biota underpin changes in susceptibility to obesity. In addition we did not observe an inflammatory response in 
the hypothalamus to HFD-induced obesity as seen in other studies1,2. Instead the striking response was a robust 
increase in the acute-phase protein SerpinA3N which was sustained throughout the period of HFD treatment. 
This provides new evidence about the pathophysiological effects of HFD-induced obesity within the neuroendo-
crine hypothalamus, potentially arising from fatty acid metabolism. These results have potentially broad signifi-
cance to our understanding of the role of diet in the development of obesity in animals as well as humans.
Methods
Ethics statement. All animal experiments were performed under strict adherence to UK Home Office 
regulations according to the Animals (Scientific Procedures) Act, 1986, and were licensed by the UK Home 
Office under Project License PPL60/4282 and approved by the local ethics committee at the Rowett Institute and 
University of Aberdeen (Approval number: SA13/03E).
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Experimental animals. Mice used in the 8 week feeding experiment. Male mice at 6–7 weeks of age includ-
ing; 16 Toll-like receptor-4-null (TLR4−/−) mice (B6.B10ScN-Tlr4lps-del/JthJ, Stock Number 007227), and 16 
Cluster of Differentiation-14-null (CD14−/−) mice (B6.129S4-Cd14tm1Frm/J, Stock Number 003726) were pur-
chased from the Jackson Laboratory (Bar Harbor, ME, USA). Wild-Type C57BL/6J (JAX™ Mice Strain, Stock 
Number 000664) control mice at 6–7 weeks of age were obtained from a UK based breeding colony of JAX® 
Mice maintained by Charles River (Charles River, UK). All mice were housed under specific pathogen free con-
ditions in the Medical Research Facility at the University of Aberdeen. The room was maintained at 21 ± 2 °C and 
55 ± 10% relative humidity with a standard 12 h light, 12 h dark lighting regime with lights on from 7 am to 7 pm. 
Experimental diets were the HFD D12492 (60 kcal% fat) (Research Diets, Inc.) and the LFD control D12450B 
(10 kcal% fat) (Research Diets, Inc.) matched for sucrose content, (Supplementary Table 1). Mice were offered 
food and water ad libitum throughout the study.
On arrival, the mice were acclimatised for 2 weeks in group housed cages of 8 or 10 mice per cage and with ad 
libitum commercial mouse chow (Special Diet Services, Witham, UK). Sixteen mice of each genotype, Wild-Type, 
Cd14−/−, and Tlr4−/−, were switched to singly housed shoebox cages containing a grid floor and food intake 
recording started. All mice were then switched onto the LFD for 1 week. Wild-Type control mice not requiring 
food intake measurements were singly housed in solid floored cages containing sawdust bedding. For increased 
enrichment of the cage environment all cages contained a roof-suspended plastic mouse house, a plastic tunnel, 
and shredded paper for bedding and nesting. After one week on the LFD, the mice were weighed and randomised 
into weight matched diet groups. One half of the mice of each genotype were switched to the HFD, while the 
remaining mice continued the LFD for 8 weeks.
Food intake was weighed and recorded twice weekly on Monday and Thursday by weighing food added to 
the hopper and weighing uneaten food on the next measurement day. At the same time, spilt food was collected 
from the trays under the grid floor cages and weighed and deducted from the food eaten. Bodyweights for all 
mice were recorded weekly. Whole body composition (as total fat and lean masses) was quantified at the begin-
ning of the study and from then on, every 2 weeks by magnetic resonance imaging (MRI; EchoMRI, 2004, Echo 
Medical Systems, Houston, TX, USA) which measures the mass of fat and lean tissue in live animals using nuclear 
magnetic resonance (NMR) technology. The EchoMRI machine was calibrated using canola oil as a reference fat.
The study was completed after 8 weeks of feeding the experimental diets. Mice were killed by cervical disloca-
tion. Trunk blood was collected via decapitation. The brains were removed, snap frozen on dry ice and then stored 
at −80 °C. The caecum contents were collected, frozen on dry ice and then stored at −80 °C.
Mice used in the 20 week feeding experiment. Thirty-two male C57BL/6J mice were purchased at 3–4 weeks old 
from Harlan UK. Mice were acclimatized for two weeks. During the first week of acclimatization, mice were fed 
chow and during the second week, were fed the 10% LFD. Mice were divided into 4 body weight matched groups 
of 8. Two groups were fed the LFD and two groups fed the HFD for 20 weeks. Fat and lean tissue content of mice 
was determined at 4 weekly intervals using Echo MRI. After 20 weeks on LFD or HFD, mice were killed by cervi-
cal dislocation. The brain was removed from one group of LFD and one group of HFD fed mice and hypothalamic 
tissue punches prepared as described in the section on differential gene expression. Brains from the remaining 
LFD and HFD fed groups were removed, frozen on dry ice and stored at −80 °C, before further processing for in 
situ hybridization.
Mice used in the 1 week feeding Experiment. 10 male C57BL/6J mice purchased (Charles River, UK) at 7–8 weeks 
old and fed standard chow for 1 week before being divided into 2 weight matched groups of 5, and fed either LFD 
control or HFD ad libitum for 1 week with free access to water. The mice were killed by transcardial perfusion 
following terminal anaesthesia. Brains were immediately excised and processed for formalin fixation as previously 
described52.
Lipopolysaccharide binding protein ELISA. LBP serum levels of WT, Tlr4−/− and Cd14−/− mice from 
the 8 week feeding experiment were assayed by Mouse LBP ELISA Kit (Enzo Life Sciences, Switzerland) accord-
ing to the manufacturer’s protocol.
Caecal contents DNA extraction of WT, Tlr4−/− and Cd14−/− mice. DNA was extracted from caecal 
contents using a FastDNA® SPIN Kit for Feces (MP Biomedicals 116570200, MP Biomedicals SARL, Illkirch, 
France). The samples (~100 mg) were placed in a Lysing Matrix E tube with 825 µl of Sodium Phosphate Buffer, 
and 275 µl of PLS solution and processed according to the manufacturer’s instructions. Eluted DNA concentration 
and purity was assessed using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Wilmington, 
DE, USA).
PCR amplification and Illumina MiSeq sequencing. DNA extracted from caecal samples was used as a 
template for PCR amplification of the V1–V2 variable regions of the bacterial 16S rRNA gene using barcoded primers 
MiSeq-27F 5′-AATGATACGGCGACCACCGAGATCTACACTATGGTAATTCCAGGTTYGATYMTGG 
CTCAG-3′ and MiSeq-338R 5′-CAAGCAGAAGACGGCATACGAGAT-barcode-AGTCAGTCAGAAGCTGC 
CTCCCGTAGGAGT-3′ containing adaptors for downstream Illumina MiSeq sequencing. Each sample was PCR 
amplified as previously described38.
Following amplification, the quadruplicate PCR reactions for each sample were pooled, purified by ethanol 
precipitation, and the DNA was resuspended in 30 μL TE. Pooled PCR amplicons were quantified using a Qubit 
dsDNA HS Assay Kit (Invitrogen, CA, USA, Q32854) and a Qubit 2.0 Fluorometer (Invitrogen, CA, USA) follow-
ing the manufacturer’s protocol, as previously described38.
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An equimolar mix was prepared for sequencing using equimolar concentrations of DNA from each sample. 
The amount of each sample to be added was calculated using the following formula: sample volume (in microlit-
ers) = DNA conc. of the sample with highest DNA conc. of all the samples (in nanograms per microliter)/DNA 
conc. of sample (in nanograms per microliter). All samples were above the minimum accepted concentration 
of 3 ng/μL. The equimolar mixed samples were cleaned using gel purification and a Wizard SV Gel and PCR 
Clean-Up System (Promega, A9281, Madison, WI, USA), as previously described38.
Paired-end sequencing of the pooled equimolar mix of PCR products was carried out on an Illumina MiSeq 
machine, using a read length of 2 × 250 bp. Illumina MiSeq sequencing was carried out by the Centre for Genome 
Enabled Biology and Medicine, University of Aberdeen. The data obtained from Illumina MiSeq sequencing were 
analysed using the mothur software package53 and based on the mothur MiSeq standard operating procedure54. 
A DNA extraction kit blank processed with only water was included as a control. The Perseus55 chimera removal 
software was used to detect and remove chimeric molecules created during PCR amplification. The Ribosomal 
Database Project (RDP) reference database (Release 10)56 was used to assign taxonomic classifications to each 
OTU at the phylum, family, and genus levels. Single unique sequences were not removed. Sequences classified as 
belonging to the Lactococcus genus were removed from the dataset as previously described38.
The final dataset contained a total of 1,321,958 sequences. One LFD Cd14−/− sample returned only 552 
sequences and was removed from the analysis. The remaining samples ranged between 9662–53849 sequences. 
Samples were then rarefied (sub-sampled) to reduce all sequences to 9662 to equalize the sequencing depth 
between all samples. A representative sequence for each OTU was generated, and the most abundant OTUs were 
manually curated against the BLAST database.
Sequence data have been deposited in the European Nucleotide Archive and is available under study acces-
sion number (PRJEB26713) and sample accession numbers (ERS2483599 to ERS2483645) and are detailed in 
Supplementary File 1. The sequence files can be found at the address: https://www.ebi.ac.uk/ena/data/view/
PRJEB26713.
Hypothalamic RNA extraction. A hypothalamic block was dissected from each mouse brain. First, frozen 
brains were thawed from −80 °C to −20 °C and then hypothalamic tissue weighing roughly 30 mg was dissected 
with coronal cuts at stereotaxic coordinates 0.38 mm and −2.28 mm relative to Bregma57. The hypothalamus was 
removed from the remaining brain tissue by making an axial cut at the top of the third ventricle and sagittal cuts 
at the lateral margins of the optic tracts. The frozen tissue blocks were transferred into Lysis Buffer (QIAGEN, 
Hilden, Germany) containing β-mercaptoethanol, and then lysed and homogenised with zirconia beads (BioSpec 
Products, Bartlesville, OK, USA) as recommended in the QIAGEN RNeasy Mini Kit. Total RNA was isolated 
from the tissue lysate using a QIAGEN RNeasy Mini Kit (QIAGEN, Hilden, Germany) with an on-column DNase 
digestion treatment following the manufacturer’s protocol. The RNA concentration and purity of isolated RNA 
was determined with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, 
USA) with the spectral absorption at 260 and 280 nm. RNA integrity was assessed with an Agilent Bioanalyzer 
2100 (Agilent Technologies, Santa Clara, CA, USA) and using their RNA 6000 Nano chips. RNA samples were 
stored at −80 °C.
Brain sectioning and In Situ Hybridization. Coronal brain sections from the mouse hypothalamus 
included the arcuate nucleus and the paraventricular nucleus and were cut at 10 µm from the stereotaxic coor-
dinates 0.38 mm to −2.28 mm relative to Bregma57 with each sequentially cut section placed on successive slides 
numbered through 1 to 12, before returning to slide 1 and repeating the process until each slide had 5 sections, 
and such that each slide had the same representation of the brain region. The process was repeated through slide 
numbers 12–24, Slides numbered 1–12 contained the ARC region whilst slides 12–24 contained the PVN region. 
Rat hypothalamic sections used for in situ hybridization were as previously described, cut and processed52.
Representative slides from each animal were hybridized with a cross-species radiolabelled rodent-specific 
antisense riboprobe complementary to partial fragments of agouti-related peptide (AgRP)58, suppressor 
of cytokine siganalling-3 (Socs3, used for the 8 week mouse experiment)59, and serpin family A member 3N 
(Serpina3n) and the corresponsing sense fragments generated from cDNA, and were either mouse-specific or 
mouse and hamster-specific. The Serpina3n probe was provided as a gift from Prof Lynda Williams (Rowett 
Institute, University of Aberdeen) and consisted of a 543 bp cDNA mouse specific probe. Reference sequence 
information, PCR primers, and cloning vectors for this probe as well others amplified from mouse cDNA includ-
ing Tlr2, Tlr4, Tlr5, CD14 and Socs3 are listed in supplementary Table 2.
Template DNA for Riboprobe synthesis was amplified from isolated plasmid DNA by PCR with M13 for-
ward and reverse primers and GoTaq hot start polymerase (Promega, UK). The antisense and sense riboprobes 
were then amplified using T7, T3 or Sp6 RNA polymerases (Fisher Scientific UK Ltd, Loughborough, UK) as 
appropriate.
Hypothalamic mRNA expression was quantified by in situ hybridisation using established methods58,60,61. 
Briefly, brain sections were fixed, acetylated and hybridized overnight at 58 °C with sense and antisense ribo-
probes labelled with 35 S (1.0–1.5 × 1010 dpm/L). Slides were treated with RNase A, then washed two times in 2x 
SCC for 5 minutes, for 10 minutes in 1x SCC, and for 10 minutes in 0.5x SCC before a final wash in 1x SSC for 
30 minutes at 60 °C, then dried and apposed to autoradiographic film (BioMax MR; Kodak, USA) for between 
3 to 28 days depending on the strength of the radioactive signal. Autoradiographic films were scanned at 1200 
d.p.i., analysed and quantified using Image-Pro Premier software version 9.2 (Media Cybernics UK, Marlow, 
UK), which computes the integrated optical density of the signal relative to a 14 C autoradiographic microscale 
(Amersham, Pharmacia Biotech UK Ltd, Little Chalfont, UK). No signals were detected for any of the sense 
probes in the hypothalamus.
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PCR confirmation of Tlr4−/− and Cd14−/− genotype. Genotype was confirmed by PCR of DNA 
extracted a 10 mg sample of ileum from a subset of half of the mice of each genotype from gut ileum using 
QIAamp DNA Micro Kit (QIAGEN) according to the manufacturer’s protocol. Primer sequences and protocols 
were provided by The Jackson Laboratory.
Genotyping primers for Cd14 mice (strain B6.129S4-Cd14tm1Frm/J) were oIMR0662: 5′-CCGCTTCCAT 
TGCTCAGCGG-3′; oIMR1314: 5′-CCAAGTTTTAGCGCTGCGTAAC-3′; oIMR1315: 5′-GCCAGCCAAGGATA 
CATAGCC-3′. Genotyping primers for Tlr4 mice (strain B6.B10ScN-Tlr4lps-del/JthJ) were oIMR8365: 5′-GCAAG 
TTTCTATATGCATTCTC-3′; oIMR8366: 5′-CCTCCATTTCCAATAGGTAG-3′; oIMR8367: 5′-ATATGCATGA 
TCAACACCACAG-3′; and oIMR8368: 5′-TTTCCATTGCTGCCCTATAG-3′. Standard PCR reactions were 
performed using GoTaq® G2 Hot Start Polymerase (Promega) and 2 μl genomic DNA through an initial 2 min 
at 95 °C, then 30 cycles of 95 °C for 30 sec, annealing at 67 °C for CD14 or 55 °C for TLR4 for 30 secs, 72 °C 
for 30 sec, followed by 72 °C for 5 min using a T100 thermal cycler (Bio-Rad, Hertfordshire, United Kingdom). 
Amplification was confirmed using agarose gel electrophoresis. Cd14 primers produced a Wild-Type DNA band 
at 840 bp and a knockout band and 600 bp. Tlr4 primers produced a Wild-Type band at 390 bp and a knockout 
band at 140 bp (data not shown).
Quantitative PCR. Total RNA was extracted from hypothalamic tissue samples using an RNeasy® Mini 
Kit (QIAGEN, Crawley, UK) with on-column DNase digestion. Overall total RNA quality was assessed using an 
Agilent Bioanalyzer (Agilent Technologies, Santa Clara, USA) and all samples gave RIN values of >9.7. cDNA 
was synthesised using a high capacity cDNA kit and completed using a GeneAmp® PCR System 9700 ther-
mal cycler (both from Applied Biosystems Foster City, CA, USA). Relative gene expression analysis was car-
ried out in line with the Minimum Information for Publication of Quantitative Real-Time PCR Experiments 
(MIQE) guidelines62. Gapdh and 18S rRNA gene efficiencies were compared with the genes of interest and 
Gapdh chosen as the most appropriately matched reference gene for this study. Commercially available PCR 
primers were used (Qiagen, Crawley, UK) for Gapdh (reference # QT01658692), 18S rRNA gene (QT02448075), 
Socs3 (QT02488983), Tnf (QT00104006), Il6 (QT00098875), Nfκb (QT00134421), Il1b (QT01048355), Cd68 
(QT00254051), Gfap (QT00101143) and Emr1 (QT00099617). Real-time qPCR was performed using a 7500 
Fast Real-time PCR System (Applied Biosystems) using the Quantifast SYBR green detection method (Qiagen).
Differential gene expression by RNAseq (20 week feeding experiment). RNA was prepared from 
a 3 mm diameter punch of the hypothalamus was taken from freshly dissected tissue. To prepare the hypotha-
lamic punch, following the cull of each mouse, the brain was removed and cut coronally at approximately bregma 
−0.1 and −3.0. The brain slice was orientated with the caudal side face up and a 3 mm punch from the ven-
tral aspect of the hypothalamus and centrally located was removed. Punches were transferred to a microfuge 
tube and immediately frozen on dry ice. Tissue was stored at −70 °C until processed. RNA was extracted using 
the Machery-Nagel RNA isolation kit. For RNAseq, libraries were prepared with the Illumina Truseq Stranded 
mRNA kit and sequenced using the high output 1 × 75 kit on the Illumina Nextgen 500 platform producing 76 bp 
single end reads. Up to 69 million reads were produced per sample. After quality control and alignment to mouse 
reference genome using HISAT263, alignments and reads were counted at gene locations using featuresCounts64. 
EdgeR (version 3.16.5) was used to detect differential change in gene expression65 between mice on a HFD and 
LFD. RNAseq data have been deposited in the ArrayExpress database (http://www.ebi.ac.uk/arrayexpress) under 
accession number E-MTAB-6929.
Immunofluorescence. Formalin-fixed hypothalamic sections (30 μm) were washed in phosphate buffered 
saline (PBS) and blocked in 4% Donkey serum/0.25% Triton X-100 in PBS for 1 hr at room temperature. Tissues 
were then incubated overnight in 1% Donkey serum/0.25% Triton X-100/PBS solution containing the primary 
antibodies: goat anti-SerpinA3N (1:100, R&D System cat. no. AF4709) or rabbit anti-GFAP (1:500, Chemicon cat. 
no. AB5804). The next day, sections were washed in PBS and then incubated for 2.5 hr at room temperature in 1% 
Donkey serum/0.25% Triton X-100/PBS solution containing the secondary antibody: anti-goat-AF594 (1:500, 
Abcam cat. no. ab150132) or anti-rabbit-AF488 (1:500, Abcam cat. no. ab150073). After washing, tissues were 
mounted on Superfrost slides and coverslipped using Mowiol. Images were acquired by using an AXIOSKOP II 
microscope (Zeiss, Germany) and neuroanatomical landmarks identified by using the Franklin & Paxinos Mouse 
Brain Atlas (Elsevier).
Statistical analysis. For microbiota sequence data Metastats (White et al., 2009), a non-parametric T-test, 
incorporating Fisher’s exact test and the false discovery rate (FDR) was used to determine whether the propor-
tional abundance of OTUs, or phylum, were significantly different between LFD and HFD groups and between 
mouse genotypes. P values generated using Metastats were corrected with the Benjamini-Hochberg method 
(Benjamini & Hochberg, 1995) to correct for the false discovery rate across multiple comparisons. P values of 
p < 0.05 were considered significant. The observed richness (Sobs), the estimated (Chao1) total richness, the 
Shannon diversity index, and the inverse Simpson diversity index were used to calculate the bacterial diversity 
within each sample in the mothur software package53.
For qPCR data, group-wise comparisons of gene expression ratios were performed using the public domain 
program Relative Expression Software Tool (REST; http://www.gene-quantification.info/)66. The gene expression 
values were normalised to the reference gene Gapdh and the data are presented as median expression levels rela-
tive to the level in the LFD group.
Unless otherwise stated group comparisons for all data were performed using R version 3.5.0 with 
RStudio Version 1.1.443. The normal distribution of sample data being analysed was initially tested using 
the Shapiro-Wilk test. Sample groups that failed the Shapiro-Wilk test were plotted and visually assessed for 
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normality. Comparisons between normally distributed samples were analysed by One Way ANOVA followed 
by Tukey’s post-hoc test for multiple comparisons. Comparisons between skewed samples were analysed using 
Kruskal-Wallis One Way ANOVA on Ranks followed by Dunn’s test for multiple comparisons. P values of p < 0.05 
were considered significant.
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